| Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer TR Hartman, EV Demidova, RW Lesh, L Hoang, M Richardson, A Forman, ... Scientific Reports 10 (1), 13518, 2020 | 16 | 2020 |
| Interaction of germline variants in a family with a history of early‐onset clear cell renal cell carcinoma E Nicolas, EV Demidova, W Iqbal, IG Serebriiskii, R Vlasenkova, ... Molecular Genetics & Genomic Medicine 7 (3), e556, 2019 | 13 | 2019 |
| RRM2B is frequently amplified across multiple tumor types: implications for DNA repair, cellular survival, and cancer therapy W Iqbal, EV Demidova, S Serrao, T ValizadehAslani, G Rosen, S Arora Frontiers in genetics 12, 628758, 2021 | 10 | 2021 |
| Polλ promotes microhomology-mediated end-joining G Chandramouly, J Jamsen, N Borisonnik, M Tyagi, ML Calbert, ... Nature structural & molecular biology 30 (1), 107-114, 2023 | 9 | 2023 |
| Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology SM Shah, EV Demidova, RW Lesh, MJ Hall, MB Daly, JE Meyer, ... Cancer treatment reviews 104, 102337, 2022 | 7 | 2022 |
| Combination Strategies for Immune Checkpoint Inhibitors in PBRM1-mutant Renal Cell Carcinoma: To PARP or Not To PARP? EV Demidova, P Ghatalia, S Arora European urology 81 (2), 149-150, 2022 | 3 | 2022 |
| Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing EV Demidova, IG Serebriiskii, R Vlasenkova, S Kelow, MD Andrake, ... BMC genomics 24 (1), 212, 2023 | 2 | 2023 |
| Correlation of peripheral blood markers of DNA damage and immune response with chemoradiation response in patients with locally advanced rectal cancer. S Arora, E Demidova, V Avkshtol, R Lesh, AJ Browne, EA Handorf, ... Journal of Clinical Oncology 37 (15_suppl), e15109-e15109, 2019 | 2 | 2019 |
| Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity SM Shah, EV Demidova, S Ringenbach, B Faezov, M Andrake, A Gandhi, ... Cancer research communications 4 (1), 213-225, 2024 | 1 | 2024 |
| Co-occurring mutations in the POLE exonuclease and non-exonuclease domains define a unique subset of highly mutagenic tumors SM Shah, EV Demidova, S Ringenbach, B Faezov, M Andrake, P Mur, ... bioRxiv, 2022.12. 15.520593, 2022 | 1 | 2022 |
| Germline determinants of chemoradiation response in rectal cancer RW Lesh, E Demidova, A Browne, V Avkshtol, JE Meyer, S Arora International Journal of Radiation Oncology, Biology, Physics 108 (3), e546, 2020 | 1 | 2020 |
| Correction: Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity SM Shah, EV Demidova, S Ringenbach, B Faezov, M Andrake, A Gandhi, ... Cancer Research Communications 4 (5), 1398-1398, 2024 | | 2024 |
| Novel biomarkers that predict response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer A Hasan, EV Demidova, P Czyzewicz, K Devarajan, MB Einarson, ... Cancer Research 84 (6_Supplement), 2506-2506, 2024 | | 2024 |
| Molecular investigation of a polymorphic variant in JMJD1C that associates with chemoradiotherapy outcomes in locally advanced rectal and head and neck cancer A Hasan, EV Demidova, P Czyzewicz, SM Shah, K Devarajan, ... Cancer Research 84 (6_Supplement), 5143-5143, 2024 | | 2024 |
| Association of a polymorphic variant in JMJD1C with response to chemoradiotherapy in rectal cancer and head and neck cancer: Implications for a diverse population A Hasan, E Demidova, P Czyzewicz, S Shah, K Devarajan, TJ Galloway, ... CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 32 (12), 2023 | | 2023 |
| Abstract PR013: Association of a polymorphic variant in JMJD1C with response to chemoradiotherapy in rectal cancer and head and neck cancer: Implications for a diverse population A Hasan, E Demidova, P Czyzewicz, S Shah, K Devarajan, TJ Galloway, ... Cancer Epidemiology, Biomarkers & Prevention 32 (12_Supplement), PR013-PR013, 2023 | | 2023 |
| Abstract PO-032: Association of a polymorphic variant in JMJD1C with tumor recurrence after adjuvant chemoradiation therapy in head and neck squamous cell … A Hasan, EV Demidova, SM Shah, P Czyzewicz, K Devarajan, T Galloway, ... Clinical Cancer Research 29 (18_Supplement), PO-032-PO-032, 2023 | | 2023 |
| Correction: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing EV Demidova, IG Serebriiskii, R Vlasenkova, S Kelow, MD Andrake, ... BMC genomics 24 (1), 388, 2023 | | 2023 |
| Author Correction: Polλ promotes microhomology-mediated end-joining G Chandramouly, J Jamsen, N Borisonnik, M Tyagi, ML Calbert, ... Nature structural & molecular biology 30 (7), 1048, 2023 | | 2023 |
| Tumor mutation burden in colorectal cancers with POLE exonuclease and non-exonuclease domain variants. S Ringenbach, SM Shah, E Demidova, B Faezov, MD Andrake, P Mur, ... Journal of Clinical Oncology 41 (4_suppl), 224-224, 2023 | | 2023 |
Sanjeevani Arora, PhDFox Chase Cancer CenterVerified email at fccc.edu
